Tethered Capsule Endomicroscopy for Barrett's Esophagus
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to examining Barrett's Esophagus, a condition where the esophageal lining changes, often due to acid reflux. Participants will swallow a small capsule attached to a tether, which uses imaging technology to examine the esophagus. Known as Tethered Capsule Endomicroscopy (TCE), this method aims to assess its effectiveness over three years. Individuals with Barrett's Esophagus who haven't reached certain advanced stages or undergone specific treatments may qualify. As an unphased study, this trial allows participants to contribute to innovative research that could enhance future diagnostic methods.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the tethered capsule endomicroscopy device is safe for Barrett's Esophagus?
Research has shown that tethered capsule endomicroscopy (TCE) is safe for humans. Studies found no negative side effects linked to the TCE procedure. Many patients even preferred it over traditional endoscopy. Participants have tolerated the procedure well, and it has successfully produced clear images of the esophagus in most cases. This suggests that TCE is a promising and safe option for those with Barrett's Esophagus.12345
Why are researchers excited about this trial?
Tethered Capsule Endomicroscopy (TCE) is unique because it offers a non-invasive way to image Barrett's Esophagus. Unlike traditional endoscopy, which involves inserting a long tube with a camera down the throat, TCE uses a small capsule that you simply swallow. This capsule is equipped with Optical Frequency Domain Imaging (OFDI) technology, which provides high-resolution images of the esophagus lining. Researchers are excited about this method because it could make screening for Barrett's Esophagus more comfortable and accessible, potentially leading to earlier detection and better patient outcomes.
What evidence suggests that the tethered capsule endomicroscopy device is effective for Barrett's Esophagus?
Research has shown that Tethered Capsule Endoscopy (TCE) offers a promising method for examining Barrett's Esophagus. In one study, 85.2% of patients preferred TCE over traditional endoscopy, highlighting its appeal. The procedure is safe and well-tolerated, with no reported side effects. TCE produces clear images of the esophagus in 90% of cases, allowing doctors to see details without invasive methods. It also provides quick, painless 3D images of the upper digestive tract, making it a less stressful option for patients. Participants in this trial will undergo TCE using the OFDI capsule to image Barrett's Esophagus.23467
Who Is on the Research Team?
Guillermo Tearney, MD, PhD
Principal Investigator
MGH
Are You a Good Fit for This Trial?
This trial is for adults over 18 with Barrett's Esophagus (BE) but without severe cell changes or esophageal cancer. Participants must not eat solid food for at least 4 hours and only clear liquids for 2 hours before the procedure. They should be able to swallow capsules, give informed consent, and have had a standard EGD within the past 15 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Tethered Capsule Endomicroscopy (TCE) imaging to study the natural history of Barrett's Esophagus
Follow-up
Participants are monitored for safety and effectiveness after the main study period
What Are the Treatments Tested in This Trial?
Interventions
- Tethered Capsule Endomicroscopy (TCE)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Mayo Clinic
Collaborator
Kansas City Veteran Affairs Medical Center
Collaborator
National Cancer Institute (NCI)
Collaborator
National Institutes of Health (NIH)
Collaborator
Columbia University
Collaborator